centrose

Centrose is a biotechnology company engaged in the development and commercialization of therapeutics targeting disease related cells.

Centrose, LLC, a biotechnology company, engages in the development and commercialization of therapeutics targeting various disease related cells. Its products include EDC1, which targets two over-expressed proteins (Dysadherin and NKA) against various hard to treat cancers, such as non-small-cell lung cancer, pancreatic cancer, thyroid cancer, and melanoma; EDC2 that simultaneously targets the NKA and CD147 for the treatment of head and neck cancers; EDC3, which uses a CD44 specific antibody and a warhead that targets NKA for non-small-cell-lung and pancreatic cancers; and EDC4, which targets CD98 and the NKA proteins that absorb nutrients and maintain ion flux.